Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.936 EUR | +2.76% | -1.63% | -45.54% |
Apr. 04 | AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada | MT |
Apr. 03 | AB Science: reconsideration possible for masitinib in ALS | CF |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 2.240 | 2.605 | 3.130 |
Spread/Res. | -13.57% | -25.68% | -38.15% |
Spread/Supp. | +2.76% | +2.76% | +11.91% |
Support | 1.884 | 1.884 | 1.730 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- AB Stock
- Charts AB Science